WallStreetZenWallStreetZen

NASDAQ: LRMR
Larimar Therapeutics Inc Stock Ownership - Who owns Larimar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Larimar Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frank E. ThomasDirector2026-02-275,000$5.00
$25.00kBuy
James E. FlynnDirector2026-02-272,000,000$5.00
$10.00MBuy
Thomas Edward HamiltonDirector2026-02-27100,000$5.00
$500.00kBuy
Jeffrey W. ShermanDirector2026-02-275,000$5.00
$25.00kBuy
James E. FlynnDirector2026-02-271,084,010$5.00
$5.42MBuy
James E. FlynnDirector2026-02-271,084,012$5.00
$5.42MBuy
James E. FlynnDirector2026-02-27831,978$5.00
$4.16MBuy
James E. FlynnDirector2025-07-313,387,539$3.20
$10.84MBuy
James E. FlynnDirector2025-07-312,599,932$3.20
$8.32MBuy
James E. FlynnDirector2025-07-313,387,529$3.20
$10.84MBuy

1 of 1

LRMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LRMR insiders and whales buy or sell their stock.

LRMR Shareholders

What type of owners hold Larimar Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn41.55%43,164,915$167.91MInsider
Peter Barrett9.89%10,276,057$39.97MInsider
Bruce Booth9.89%10,270,758$39.95MInsider
Aigh Capital Management LLC2.89%3,000,000$11.67MInstitution
Vanguard Capital Management LLC2.76%2,866,349$11.15MInstitution
Deerfield Partners LP2.67%2,777,777$10.81MInsider
Thomas Edward Hamilton0.95%983,664$3.83MInsider
Dimensional Fund Advisors LP0.77%798,462$3.11MInstitution
Nuveen LLC0.65%674,915$2.63MInstitution
Jane Street Group LLC0.53%554,007$2.16MInstitution

1 of 3

LRMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LRMR9.53%66.72%Net BuyingNet Buying
XFOR14.40%8.45%Net BuyingNet Selling
GLSI4.69%94.25%Net Buying
YDES0.07%3.64%
VNDA19.90%69.33%Net SellingNet Selling
View Top Biotech Stocks

Larimar Therapeutics Stock Ownership FAQ

Who owns Larimar Therapeutics?

Larimar Therapeutics (NASDAQ: LRMR) is owned by 9.53% institutional shareholders, 66.72% Larimar Therapeutics insiders, and 23.75% retail investors. James E. Flynn is the largest individual Larimar Therapeutics shareholder, owning 43.16M shares representing 41.55% of the company. James E. Flynn's Larimar Therapeutics shares are currently valued at $154.53M.

If you're new to stock investing, here's how to buy Larimar Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.